Updated data from a phase II dose finding trial of single agent isatuximab (SAR650984, Anti-CD38 Mab) in relapsed/refractory multiple myeloma (RRMM) Meeting Abstract
| Authors: | Vij, R.; Martin, T.; Richter, J.; Cole, C.; Atanackovic, D.; Zonder, J.; Kaufman, J.; Mikhael, J.; Bensinger, W.; Dimopoulos, M.; Zimmerman, T.; Lendvai, N.; Hari, P.; Ocio, E. M.; Gasparetto, C.; Kumar, S.; Oprea, C.; Charpentier, E.; Strickland, S.; San Miguel, J. |
| Abstract Title: | Updated data from a phase II dose finding trial of single agent isatuximab (SAR650984, Anti-CD38 Mab) in relapsed/refractory multiple myeloma (RRMM) |
| Meeting Title: | 21st Congress of the European Hematology Association (EHA) |
| Journal Title: | Haematologica |
| Volume: | 101 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2016 Jun 9-12 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2016-06-01 |
| Start Page: | 82 |
| End Page: | 83 |
| Language: | English |
| ACCESSION: | WOS:000379484600177 |
| PROVIDER: | wos |
| PMCID: | PMC4894295 |
| Notes: | Meeting Abstract: P274 -- 21st Congress of the European-Hematology-Association -- JUN 09-12, 2016 -- Copenhagen, DENMARK -- Source: Wos |
MSK Authors
-
106Lendvai